Rasagiline: Phase III data

In the U.S. and Canadian Phase III TEMPO trial in 436 patients, 26

Read the full 139 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE